Home > Balance Sheet > PIRAMAL PHARMA

PIRAMAL PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-145 Cr₹-157 Cr₹-130 Cr₹-105 Cr₹-22 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of PIRAMAL PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of PIRAMAL PHARMA is ₹-145 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-145 Cr
Mar2024₹-157 Cr
Mar2023₹-130 Cr
Mar2022₹-105 Cr
Mar2021₹-22 Cr

How is Deferred Tax Assets / Liabilities of PIRAMAL PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-145 Cr
Negative
Mar2024 ₹-157 Cr
Negative
Mar2023 ₹-130 Cr
Negative
Mar2022 ₹-105 Cr
Negative
Mar2021 ₹-22 Cr -

Compare Deferred Tax Assets / Liabilities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹21,087.8 Cr 2.2% -12.3% -31% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

2.2%

-12.3%

-31%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses